Cancer marker and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8435734
APP PUB NO 20080299579A1
SERIAL NO

12129923

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides a method for cancer diagnosis comprising measuring an endogenous antisense RNA whose relative expression to a sense RNA changes cancer-specifically in RNA-containing samples collected from a mammal. Also provided are endogenous antisense RNAs useful as cancer markers, and cancer diagnostic reagents containing the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIKEN2-1 HIROSAWA WAKO-SHI SAITAMA 351-0198
NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES1-2 KANNONDAI 2-CHOME TSUKUBA-SHI IBARAKI 305-8602
UNIVERSITY OF TSUKUBA1-1-1 TENNODAI TSUKUBA-SHI IBARAKI 305-8577

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kiyosawa, Hidenori Tsukuba, JP 2 0
Ohkohchi, Nobuhiro Tsukuba, JP 7 6
Yasue, Hiroshi Tsukuba, JP 4 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 7, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00